{"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"groups":[{"description":"Participants received carfilzomib 20 milligram per meter square (mg/m\\^2) intravenously (IV) on Cycle 1 Day 1 and then 70 mg/m\\^2 on Cycle 1 Days 8 and 15, and thereafter on Days 1, 8, 15 from Cycle 2 onwards. Participants received dexamethasone 20 milligrams (mg) on Cycle 1 Days 1 and 2, and 40 mg IV or orally on Days 8, 15, 22 of Cycle 1. Participants then received dexamethasone 40 mg IV or orally on Days 1, 8, 15 and 22 of Cycles 2-9, then on Days 1, 8, 15 from Cycle 10 onwards, until confirmed progressive disease (PD), death, intolerable toxicity, start of a new treatment for multiple myeloma, withdrawal of consent, or end of the study, whichever occurs first. Each cycle of 28 days.","id":"BG000","title":"Arm A: Carfilzomib+Dexamethasone (Kd)"},{"description":"Participants received daratumumab 1800 mg by SC injection (Dara-SC) on Days 1, 8, 15, 22 of Cycle 1 and 2, Days 1 and 15 of Cycle 3-6, and on Day 1 from Cycle 7 onwards. Participants received carfilzomib 20 mg/m\\^2 IV on Cycle 1 Day 1 and then 70 mg/m\\^2 on Cycle 1 Days 8 and 15, and Days 1, 8 and 15 from Cycle 2 onwards. Participants received dexamethasone 20 mg on Cycle 1 Days 1 and 2 and 40 mg IV or orally on Days 8, 15, 22 of Cycle 1. Participants then received dexamethasone 40 mg IV or orally on Days 1, 8, 15 and 22 of Cycles 2-9, then on Days 1, 8, 15 from Cycle 10 onwards, until confirmed PD, death, intolerable toxicity, start of a new treatment for multiple myeloma, withdrawal of consent, or end of the study, whichever occurs first. Each cycle of 28 days.","id":"BG001","title":"Arm B: Dara-SC in Combination With Kd (DKd)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.56","value":"67.4"},{"groupId":"BG001","spread":"9.72","value":"66.7"},{"groupId":"BG002","spread":"9.12","value":"67"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Children (2-11 years)"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Adolescents (12-17 years)"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"31"}],"title":"Adults (18-64 years)"},{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"54"}],"title":"From 65 to 84 years"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"85 years and over"}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"39"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"49"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"20"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"55"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"13"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"75"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"BELGIUM"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"BRAZIL"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"CANADA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"DENMARK"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"FRANCE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"GERMANY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"GREECE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"ITALY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"NETHERLANDS"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"POLAND"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"10"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"RUSSIAN FEDERATION"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"11"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"SPAIN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"88"}],"units":"Participants"}],"title":"UNITED STATES"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"Anti-CD38 antibody only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"Both PI and IMiD"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"25"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"IMiD + anti-CD38"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"IMiD only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"PI + IMiD + anti-CD38"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"86"}],"units":"Participants"}],"title":"PI only"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Here, 'N' (number of subjects analyzed) signifies participants who were evaluable for this baseline characteristics.","title":"Refractory status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"36"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"87"}],"units":"Participants"}],"title":"STAGE I"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"30"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"87"}],"units":"Participants"}],"title":"STAGE II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"21"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"87"}],"units":"Participants"}],"title":"STAGE III"}],"description":"The International Staging System (ISS) system consists of stage I: beta2-microglobulin less than (\\<)3.5 milligram per liter (mg/l) and albumin greater than or equal to (\\>=) 3.5 gram (g) per 100 milliliter (mL) (g/100 mL); stage II: neither stage I nor stage III and stage III: beta2-microglobulin \\>= 5.5 mg/l.","paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Here, 'N' (number of subjects analyzed) signifies participants who were evaluable for this baseline characteristics.","title":"Stage of Disease (ISS)","unitOfMeasure":"Participants"}]}